CVA Family Office’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
VCM
VPM
CVA Family Office's ZBH Position: Q1 2026 in Review
CVA Family Office increased its Zimmer Biomet (ZBH) stake by 150% in Q1 2026, buying an estimated $8.26K and bringing the position to 150 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #902.
CVA Family Office first reported a position in ZBH in Q1 2021 and has held it in 19 quarters since. The position peaked at $48K in Q4 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- CVA Family Office held 150 shares of Zimmer Biomet worth $13.6K as of Q1 2026.
- CVA Family Office bought 90 Zimmer Biomet shares in Q1 2026, an estimated $8.26K.
- Zimmer Biomet made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #902 holding.
- CVA Family Office first reported a position in Zimmer Biomet in Q1 2021 and has held it in 19 quarters since.
- CVA Family Office's Zimmer Biomet position peaked at $48K in Q4 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.